Clinical Trial Update: Mirabegron as Medical Expulsive Therapy (MET) for Ureteral Stones and Ureteral Stent Pain [Phase 2]

View source ↗

Summary

Phase 2 trial update of mirabegron as medical expulsive therapy for ureteral stones and ureteral stent pain has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Flank Pain
• Ureteral Obstruction

Drugs mentioned

• Mirabegron (mirabegron)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Ureteral Obstruction, Flank Pain | Phase 2 | Status: COMPLETED | Results posted: 2022-04-26